The data show that Tregs are present within the cell populations obtained from BAL, tracheal aspirates, and peripheral blood of patients with ARDS, as measured by the percentage of CD4+ lymphocytes that are FOXP3+ (Fig. 1). This evidence concerns the gene CD4 and acute respiratory distress syndrome.